Professor Raph L Hamers
Developing collaborative clinical trials in Indonesia
Indonesia is a very populous country with a huge burden of infectious diseases such as TB, malaria, HIV and CNS infections. Running clinical trials requires high levels of expertise, currently developed and strengthened by institutions such as IOCRL (Universities of Indonesia and Oxford Clinical Research laboratory). Better collaborations will also help great ideas make a bigger impact.
- Associate Professor, University of Oxford
- Clinical Infectious Diseases Research Programme Leader EOCRU Jakarta
- Manager of the Universities of Indonesia and Oxford Clinical Research Laboratory (IOCRL)
- Internist and infectious disease physician
Eijkman Oxford Clinical Research Unit (EOCRU)
Raph Hamers MD PhD is an internist and infectious disease physician, trained in The Netherlands and Tanzania, and an Associate Professor at University of Oxford, based at the Eijkman-Oxford Clinical Research Unit (EOCRU) in Jakarta, Indonesia. He holds a PhD from the University of Amsterdam, and is a recipient of a Veni postdoc fellowship through the Netherlands Organization for Scientific Research (NWO) Talent Programme. He is an honorary consultant internist at the Amsterdam University Medical Centres (AMC) and honorary research fellow at Faculty of Medicine University of Indonesia (FKUI). His research to date has been centered on the clinical management, molecular epidemiology, drug resistance and immunology of HIV-1 infection in sub-Saharan Africa.
After joining EOCRU in Jakarta in 2017, he established the Clinical Infectious Disease Research Programme, with a focus on 1) clinical management of tuberculosis meningitis; 2) strategies to assess antibiotic use and resistance to inform tailored stewardship interventions in LMIC; 3) emerging infectious diseases in Indonesia (including projects on leptospirosis, HFMD, febrile illness, and COVID-19). His work emphasizes multidisciplinary approaches to improving health outcomes in low-resource settings, strengthening local research capacity and developing a broader collaborative clinical research agenda in Indonesia, working with EOCRU's principal partners FKUI, Eijkman Institute for Molecular Biology and the broader Oxford Tropical Network. In support of this growing research portfolio, in 2018 he established the Universities of Indonesia-Oxford Clinical Research Laboratory (IOCRL) on the FKUI premises in Jakarta, a facility that serves as a Clinical Trials Unit and hub for research training and public and community engagement with science in Indonesia.
Horby PW. et al, (2021)
Revell AD. et al, (2021), The Journal of antimicrobial chemotherapy, 76, 1898 - 1906
Limato R. et al, (2021), JAC-antimicrobial resistance, 3
Lim C. et al, (2021), Clinical Microbiology and Infection
Horby PW. et al, (2021)
van Crevel R. and ULTIMATE consortium None., (2021), Tuberculosis (Edinburgh, Scotland), 128
Surendra H. et al, (2021), The Lancet Regional Health. Western Pacific, 9
Schilling WHK. et al, (2021), Wellcome Open Research, 6, 71 - 71
Schilling WH. et al, (2021), Wellcome open research, 6
Kroeze S. et al, (2020), The Journal of infectious diseases